Skip to content

Evaluating the Effect of Subcutaneous Dexamethasone Added to Bupivacaine on Postcesarean Pain Relief

Evaluating the Effect of Subcutaneous Dexamethasone Added to Bupivacaine on Postcesarean Pain Relief

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT138809242405N3
Enrollment
75
Registered
2010-01-20
Start date
2008-07-29
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications of anaesthesia during pregnancy. Other complications of anaesthesia during pregnancy

Interventions

Intervention 1: bupivacaine 20 ml,0.25% (SC) + dexamethasone 4 ml (16 mg) (SC) +Normal saline 4 ml iv, Duration of treatment: single dose . Intervention 2: bupivacaine 20 ml,0.25%(SC) + dexamethasone
Treatment - Drugs
bupivacaine 20 ml,0.25% (SC) + dexamethasone 4 ml (16 mg) (SC) +Normal saline 4 ml iv, Duration of treatment: single dose .
bupivacaine 20 ml,0.25%(SC) + dexamethasone 4 ml (16 mg) iv+ Normal saline 4 ml iv, Duration of treatment: single dose .
bupivacaine 20 ml,0.25% (SC) + normal saline 4 ml SC+ normal saline 4 ml iv (placebo group). Duration of treatment: single dose .

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Parturients, ASA physical status I-II, scheduled for elective cesarean section, under general anesthesia. Exclusion Criteria: patients with suspected or manifest bleeding disturbances, allergy to Bupivacaine or Dexamethasone, atopia, diabetes mellitus, the presence of liver or kidney diseases, abuse of drugs and patients with pregnant induced hypertension or preeclampsia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: recovery room ,6 , 12, 24, 48 and 72 hours postoperative. Method of measurement: Visual Analogous Scale (VAS) and scoring from 0 to 10.

Secondary

MeasureTime frame
Systolic blood pressure. Timepoint: at recovery room ,6 , 12, 24, 48 and 72 hours postoperative. Method of measurement: using mercury manometer.;Diastolic blood pressure. Timepoint: at recovery room ,6 , 12, 24, 48 and 72 hours postoperative. Method of measurement: using mercury manometer.;Opioid consumption. Timepoint: at recovery room ,6 , 12, 24, 48 and 72 hours postoperative. Method of measurement: mili gram of opioid.;Heart rate. Timepoint: at recovery room ,6 , 12, 24, 48 and 72 hours postoperative. Method of measurement: Using EKG Monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMs. Leila Bakhshi

Research Brueae, Medical School, Isfahan University of Medical Sciences

jabalameli@med.mui.ac.ir+98 31 1792 2269

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026